A UCLA-led research team has discovered a molecular switch that determines whether tiny blood vessels in premature infants' ...
Experts are seeing a significant rise in respiratory issues in newborns lately which concerns first-time parents more In this ...
Nirsevimab, a long-acting monoclonal antibody that confers passive immunity for infants up to 6 months old, was approved in ...
Respiratory syncytial virus (RSV) is the leading global cause of death in children under age five years, and lacks an effective vaccine. A study by researchers for Precision Vaccines Program at Boston ...
A recent case report from the researchers at the University of São Paulo, published in the journal CLINICS, shows how newborns can also be infected with severe acute respiratory syndrome coronavirus 2 ...
As several European countries are currently detecting respiratory syncytial virus (RSV) infections, ECDC issues rapid scientific advice for policymakers and public health authorities on ways to ...
Please provide your email address to receive an email when new articles are posted on . Minimally invasive surfactant therapy did not lower mortality among preterm infants with respiratory distress ...
In last month’s column I discussed the importance of uninterrupted skin-to-skin contact for newborn babies. What is extraordinary about this magical first hour after birth is that, if left ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback